This initiative aims to expand and strengthen the contribution of South African investigators to HIV vaccine research through a structured research, mentorship and PhD program. SHAPe seeks to build research capacity by helping to develop and foster the careers of early stage investigators (ESIs) interested in clinical trials, laboratory and epidemiological research that support preventative HIV vaccine development.
SHAPe identifies, supports and works toward retaining young clinicians interested in committing to a career in HIV research. Working closely with established South African HIV vaccine researchers, ESIs identify research questions addressing priorities of the HVTN scientific agenda, and design novel research to conduct within the framework and support of an HIV vaccine research unit.
Funding and Support
This program is supported by the HIV Vaccine Trials Network and the Desmond Tutu HIV Centre (DTHC), with funding from the National Institute of Allergy and Infectious Diseases (NIAID) and the Fogarty International Center of the US National Institutes of Health.